Quest Diagnostics Inc Business Acquisition, Pro Forma Earnings Per Share, Diluted
Quest Diagnostics Inc (DGX) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of $7.67 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2026-02-26
- Quest Diagnostics Inc business acquisition, pro forma earnings per share, diluted for the quarter ending 2024-09-30 was $1.95, a 1.02% decline year-over-year.
- Quest Diagnostics Inc business acquisition, pro forma earnings per share, diluted for the quarter ending 2024-06-30 was $2.07.
- Quest Diagnostics Inc business acquisition, pro forma earnings per share, diluted for the quarter ending 2024-03-31 was $1.70.
- Quest Diagnostics Inc business acquisition, pro forma earnings per share, diluted for the quarter ending 2023-09-30 was $1.97.
- Quest Diagnostics Inc business acquisition, pro forma earnings per share, diluted for fiscal 2024 was $7.67, a 3.93% increase from fiscal 2023.
- Quest Diagnostics Inc business acquisition, pro forma earnings per share, diluted for fiscal 2023 was $7.38.
- Quest Diagnostics Inc business acquisition, pro forma earnings per share, diluted for fiscal 2014 was $3.77, a 29.66% decline from fiscal 2013.
- Quest Diagnostics Inc business acquisition, pro forma earnings per share, diluted for fiscal 2013 was $5.36.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2024-12-31 | $7.67 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $1.95 10-Q · filed 2025-10-21 | $5.72 10-Q · filed 2025-10-21 | ||
| 2024-06-30 | $2.07 10-Q · filed 2025-07-23 | $3.77 10-Q · filed 2025-07-23 | ||
| 2024-03-31 | $1.70 10-Q · filed 2025-04-23 | |||
| 2023-12-31 | $7.38 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $1.97 10-Q · filed 2024-10-23 | $5.79 10-Q · filed 2024-10-23 | ||
| 2014-12-31 | $3.77 10-K · filed 2017-02-22 | |||
| 2014-09-30 | $2.50 10-Q · filed 2014-10-30 | |||
| 2014-06-30 | $0.92 10-Q · filed 2014-07-31 | $1.62 10-Q · filed 2014-07-31 | ||
| 2014-03-31 | $0.70 10-Q · filed 2015-04-30 | |||
| 2013-12-31 | $5.36 10-K · filed 2016-02-26 | |||
| 2013-09-30 | $2.70 10-Q · filed 2014-10-30 | $4.36 10-Q · filed 2014-10-30 | ||
| 2013-06-30 | $1.00 10-Q · filed 2014-07-31 | $1.71 10-Q · filed 2014-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |